124.
125.
126.
Crile, G. Jr.
Changing end results in patients with papillary carci-
noma of the thyroid.
Surg. Gynecol. Obstet. 132: 460-8 (1971).
Hazard, J.B., Crile, G. Jr., and Dempsey, W.S.
osing tumors of the thyroid.
Nonencapsulated scler-
J. Clin. Endocrinol. 9: 1215 (1949).
Franssila, K.O.
Prognosis in thyroid carcinoma. Cancer 36: 1138-46
(1975).
Hazard, J.B. Small papillary carcinoma of the thyroid: A study with
Special reference to so-cailed nonencapsulated sclerosing tumor.
Invest. 9: 86-97 (1960).
Lab.
127.
Klinck, G.B. and Winship, T.
128.
Williams, E.D. The pathology of thyroid malignancy. Br. J. Surg. 62:
757-9 (1975).
Sampson, R.J., Oka, H., Key, C.R., Bunmcher, C.R., and Iijima, S.
Metastases from occult thyroid carcinoma: An autopsy study fcom
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
roid.
Cancer 8: 701 (1955).
Hiroshima and Nagasaki, Japan.
Fukunaga, F.H. and Yatani, R.
carcinomas.
Occult sclerosing carcinoma of the thy-
Cancer 25: 803-11 (1970).
Geographic pathology of occult thyroid
Cancer 36: 1095-9 (1975).
Sawin, C.T. and Hershman, J.M.
The TSH response to thyrotropin-
releasing hormone (TRH) in voung adult men: Intra~individual variation
and relation to basal serum TSH and thyroid hormones. J. Clin.
Endocrinol. Metab. 46: 217 (1978).
Thein-Wai, W. and Larsen, P.R. Effects of weekly thyroxine administration on serum thyroxine and 3,5,3'-triiodothyronine, thyrotropin and
thyrotropin response to thyrotropin-releasing hormone. J. Clin.
Endocrinol. Metab. 50: 660 (1980).
Tunbridge, W.M.G., Evered, D.C., Hall, R., Appleton, D., Brewis, M.,
Clark, F., Grimley Evans, J., Young, E., Bird, T., and Smith, P.A.
The
spectrum of thyroid disease in a commnity: The Wickham survey. Clin.
Endocrinol. 7: 481 (1977).
Van Middlesworth, L. Factors influencing the thyroid uptake of iodine
isotopes from nuclear fission: A review. Health Phys. 9: 1197-1211
(1963).
Evans, T.C., Kretzchmar, R.H., Hodges, R.E., and Song, C.W. Radioiodine
uptake studies of the human fetal thyroid. J. Nucl. Med. 8: 157-60
(1967).
Hodges, R.E., Evans, T.C., Bradbury, J.T., and Keettel, W.C.
mulation of radioactive iodine by human fetal thyroids.
Endocrinol. Metab. 15: 661-7 (1955).
Mays, C.W.
The accu-
J. Clin.
(University of Utah), Personal communication, 1974.
Russel, K.P., Rowse, H., and Starr, P. The effects of radioactive iodine
in maternal and fetal thyroid function during pregnancy. Surg. Gynecol.
Obstet. 104: 560-4 (1957).
Fisher, W.D., Voorhess, M.L., and Gardner, L.I. Congenital hypothyroidism in infant following maternal qi31 therapy. with a review of hazards
of environmental radioisotope contamination. J. Pediat. 62: 132-46
(1963).
Hamill, G.C., Jarman, J.A., and Wynne, M.D.
Fetal effects of radio-
active iodine therapy in a pregnant woman with thyroid cancer.
Obstet. Gynecol. 81: 1018-23 (1961).
- 96
_ SEE
Am. J.
-
_—-
123.